Latest News
BioSyent Inc.
- Is BioSyent’s (TSXV:RX) Quarterly Dividend Safe After an Oral Health Acquisition Drained Its Cash?
- BioSyent Inc. (TSXV:RX) Stock Slides as Healthcare Valuation Concerns and Market Caution Cloud Near-Term Outlook
- BioSyent to Present at Planet MicroCap Toronto
- BioSyent Inc. (TSXV:RX) Climbs 4.43% as Buying Momentum Lifts Outlook on 16 October 2026
- BioSyent Inc.(TSXV: RX) added to S&P/TSX Venture Composite Index
- BioSyent Shares Slides 6.88% as Specialty Pharma Valuation Scrutiny and Integration Headwinds Pressure Investor Sentiment
- BioSyent Inc. (TSXV:RX) Gains Momentum as Specialty Healthcare Expansion and Diversified Growth Support Investor Confidence
Headlines from the last 30 days, linking to the original publishers. See all market news →